Nycomed Finds Commercialisation Partner for Ciclesonide

By Business Review Editor

Pharma Deals Review: Vol 2008 Issue 93 (Table of Contents)

Published: 8 Mar-2008

DOI: 10.3833/pdr.v2008.i93.211     ISSN: 1756-7874

Section: Licensing

Fulltext:

Abstract

Sepracor and Nycomed entered into licensing agreement to develop, market and commercialize rights to ciclesonide for treating asthma...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details